Cardiac GR and MR: From Development to Pathology.

Trends Endocrinol Metab

Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. Electronic address:

Published: January 2016

The efficacy of mineralocorticoid receptor (MR) antagonism in the treatment of certain patients with heart failure has highlighted the pivotal role of aldosterone and MR in heart disease. The glucocorticoid (GC) receptor (GR) is also expressed in heart, but the role of cardiac GR had received much less attention until recently. GR and MR are highly homologous in both structure and function, although not in cellular readout. Recent evidence in animal models has uncovered a tonic role for GC action via GR in cardiomyocytes in prevention of heart disease. Here, we review this evidence and the implications for a balance between GR and MR activation in the early life maturation of the heart and its subsequent health and disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tem.2015.10.001DOI Listing

Publication Analysis

Top Keywords

heart disease
8
heart
5
cardiac development
4
development pathology
4
pathology efficacy
4
efficacy mineralocorticoid
4
mineralocorticoid receptor
4
receptor antagonism
4
antagonism treatment
4
treatment patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!